Cargando…

Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models

Group A Streptococcus (GAS) is an important human pathogen responsible for both superficial infections and invasive diseases. Autoimmune sequelae may occur upon repeated infection. For this reason, development of a vaccine against GAS represents a major challenge, since certain GAS components may tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera-Hernandez, Tania, Pandey, Manisha, Henningham, Anna, Cole, Jason, Choudhury, Biswa, Cork, Amanda J., Gillen, Christine M., Ghaffar, Khairunnisa Abdul, West, Nicholas P., Silvestri, Guido, Good, Michael F., Moyle, Peter M., Toth, Istvan, Nizet, Victor, Batzloff, Michael R., Walker, Mark J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916377/ https://www.ncbi.nlm.nih.gov/pubmed/27302756 http://dx.doi.org/10.1128/mBio.00618-16

Ejemplares similares

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma
por: Pandey, Manisha, et al.
Publicado: (2016)

An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
por: Rivera-Hernandez, Tania, et al.
Publicado: (2019)

Erratum for Rivera-Hernandez et al., “An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model”
por: Rivera-Hernandez, Tania, et al.
Publicado: (2020)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007
por: Steer, Andrew C., et al.
Publicado: (2009)

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy
por: Pandey, Manisha, et al.
Publicado: (2018)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Mechanisms of group A Streptococcus resistance to reactive oxygen species
por: Henningham, Anna, et al.
Publicado: (2015)

Inflammasome/IL-1β Responses to Streptococcal Pathogens
por: LaRock, Christopher N., et al.
Publicado: (2015)

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Streptococcal M1 protein constructs a pathological host fibrinogen network
por: Macheboeuf, Pauline, et al.
Publicado: (2011)

Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches
por: Patras, Kathryn A., et al.
Publicado: (2018)

Plasmodium berghei bio-burden correlates with parasite lactate dehydrogenase: application to murine Plasmodium diagnostics
por: De, Sai Lata, et al.
Publicado: (2016)

Group B Streptococcal β-Hemolysin/Cytolysin Directly Impairs Cardiomyocyte Viability and Function
por: Hensler, Mary E., et al.
Publicado: (2008)

Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A(2) to exert its bactericidal effects
por: van Hensbergen, Vincent P., et al.
Publicado: (2018)

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023)

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice
por: Pandey, Manisha, et al.
Publicado: (2019)

Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence
por: Sjögren, Jonathan, et al.
Publicado: (2011)

Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of Histones
por: Döhrmann, Simon, et al.
Publicado: (2017)

The quest for GAS vaccine
por: Pandey, Manisha, et al.
Publicado: (2015)

Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome
por: Sendi, Parham, et al.
Publicado: (2009)

Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysis
por: Yoonim, Nonglak, et al.
Publicado: (2005)

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial
por: Sekuloski, Silvana, et al.
Publicado: (2018)

Stability of the Octameric Structure Affects Plasminogen-Binding Capacity of Streptococcal Enolase
por: Cork, Amanda J., et al.
Publicado: (2015)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

STREPTOCOCCAL M ANTIGEN LOCATION AND SYNTHESIS, STUDIED BY IMMUNOFLUORESCENCE
por: Hahn, Jerome J., et al.
Publicado: (1963)

Mutual Exclusivity of Hyaluronan and Hyaluronidase in Invasive Group A Streptococcus
por: Henningham, Anna, et al.
Publicado: (2014)

Streptococcal Infections
por: Boisvert, Paul L.
Publicado: (1954)

The Streptococcal Tendency
Publicado: (1939)

The Streptococcal Diseases
por: Thomson, Scott
Publicado: (1938)

Streptococcal Infections
por: Gray, Barry M., et al.
Publicado: (2009)

Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus
por: Henningham, Anna, et al.
Publicado: (2013)

Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A Streptococcus
por: Henningham, Anna, et al.
Publicado: (2018)

Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal β Protein
por: Nordström, Therése, et al.
Publicado: (2011)

Streptococcal Septicæmia: A Case Successfully Treated with Streptococcal (Scarlatinal) Antitoxin
por: Fleming, John
Publicado: (1934)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h1o5ssk8pituhu5fjmkuc9uf36